Surgical treatment of prostate cancer (PCa) in patients older than 70 years is controversially discussed. Although the prevalence and presumably also the aggressiveness of PCa increase with age, a survival advantage by radical prostatectomy (RPx) is questionable. The current review will discuss the oncological outcome of RPx in the elderly. Moreover, the pros and cons of different surgical approaches will be evaluated.